GlassScriptPhysician profile
Travis T Sims
NPI 1962822650
$13,649.76
in general payments reported to CMS, 2019-2025
10 companies · $4,415 in 2025
The $4,415 reported for 2025 was more than what 85% of Gynecologic Oncology providers received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.00 · 2021: $225 · 2022: $262 · 2023: $2,166 · 2024: $6,483 · 2025: $4,415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,553 · Food and Beverage: $1,812 · Grant: $1,665 · Travel and Lodging: $1,034.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,552.50 |
| Food and Beverage | $1,812.19 |
| Grant | $1,665.44 |
| Travel and Lodging | $1,033.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $10,474.04 | 2023-2025 | Lynparza |
| Medical Device Business Services, INC. | $1,404.49 | 2024 | Enseal |
| Ethicon US, LLC | $648.49 | 2022-2025 | Enseal, Dermabond Prineo, Stratafix |
| Stryker Corporation | $310.63 | 2021-2022 | |
| Intuitive Surgical, INC. | $203.96 | 2022-2024 | |
| Immunogen, INC. | $178.02 | 2023 | Elahere |
| Abbvie INC. | $124.19 | 2025 | |
| Pfizer INC. | $106.55 | 2024 | |
| Daiichi Sankyo INC. | $100.39 | 2025 | Enhertu |
| Clovis Oncology, INC. | $99.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Travis Sims listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.